Meeting
2022 ASCO Annual Meeting
Human papillomavirus (HPV) vaccine hesitancy trends in the United States.
Authors
Eric Adjei Boakye
Henry Ford Health System, Detroit, MI
Eric Adjei Boakye , Dina K Abouelella , Mrudula Nair , Nosayaba Osazuwa-Peters
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10550)
DOI
10.1200/JCO.2022.40.16_suppl.10550
Abstract #
10550
Poster Bd #
426
Abstract Disclosures
Similar Posters
First Author: Thanuja Neerukonda
Poster
2023 ASCO Annual Meeting
Efficacy and safety of combining PD-1 blockage and human papillomavirus vaccine for patients with relapsed/refractory advanced cervical cancer.
First Author: Buhai Wang
Poster
2022 ASCO Annual Meeting
The role of health information technology in improving awareness of HPV and HPV vaccine among U.S. adults: Insights from the health information national trends survey.
First Author: Gideon T Dosunmu
Poster
2020 ASCO Virtual Scientific Program
Complete human papillomavirus vaccination coverage over a 13-year period in a large population of privately insured U.S. patients.
First Author: Yull Edwin Arriaga